Last reviewed · How we verify
C: moxifloxacin
At a glance
| Generic name | C: moxifloxacin |
|---|---|
| Also known as | C: moxifloxacin 400mg |
| Sponsor | CTI BioPharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C: moxifloxacin CI brief — competitive landscape report
- C: moxifloxacin updates RSS · CI watch RSS
- CTI BioPharma portfolio CI